COMMUNIQUÉS West-GlobeNewswire

-
HealthEquity 2025 Benefits Trends Unveiled: Cost Transparency and Containment Take Center Stage for Administrators
03/12/2024 -
BioAdaptives, Inc.’s Board of Directors Approves a One-for-One Stock Dividend
03/12/2024 -
Hapbee Unveils Revolutionary Digital Sleep Solution to Address the Global Sleep Crisis
03/12/2024 -
KYZATREX® (testosterone undecanoate) CIII Capsules EXPANDS DISTRIBUTION THROUGH NEW COLLABORATION WITH GAMEDAY MEN’S HEALTH
03/12/2024 -
Philips aims to advance cardiac MRI technology through AI-driven research
03/12/2024 -
Femasys Announces Partnership with HRC Fertility, Esteemed Conglomerate Provider of Fertility Services in Western U.S., to Offer FemaSeed
03/12/2024 -
Aeroflow Health Announces Giving Tuesday Donations to Organizations in Western North Carolina
03/12/2024 -
Soda Health closes oversubscribed $50M Series B led by General Catalyst to scale its Smart Benefits Operating System
03/12/2024 -
Alira Health Unveils 2024 Report on Antibody-Drug Conjugates Market
03/12/2024 -
Evoke Pharma Receives Notices of Allowance for Two Additional US Patent Applications Protecting GIMOTI®
03/12/2024 -
Adial Pharmaceuticals Granted Key U.S. Patent for the Treatment of Alcohol and Drug Dependence Based on Expanded Genotype Combinations
03/12/2024 -
Dentsply Sirona to Participate in the 7th Annual Evercore ISI HealthCONx Conference
03/12/2024 -
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02/12/2024 -
Revolution Medicines Announces Commencement of Public Offering of Common Stock
02/12/2024 -
Jasper Therapeutics Announces First Patient Dosed in Phase 1b/2a ETESIAN Clinical Study of Briquilimab in Asthma
02/12/2024 -
MacroGenics to Participate in Upcoming Investor Conference
02/12/2024 -
Information regarding the total number of voting rights and total number of shares of the Company as of November 30, 2024
02/12/2024 -
Information relative au nombre total des droits de vote et d’actions composant le capital social au 30 novembre 2024
02/12/2024 -
Treace Appoints Guy Guglielmino as Chief Commercial Officer
02/12/2024
Pages